Funding for this research was provided by:
Chiesi Ltd UK
Article History
Received: 16 June 2020
Accepted: 29 November 2020
First Online: 9 December 2020
Ethics approval and consent to participate
: All patients provided written informed consent using a protocol approved by the Health & Social Care Research Ethics Committee A (18/NI/0194).
: Not applicable.
: JD; The author declares that they have no competing interests. CP; The author declares that they have no competing interests. NK; The author declares that they have no competing interests. DS has received sponsorship to attend international meetings, honoraria for lecturing or attending advisory boards and research grants from various pharmaceutical companies including AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, Genentech, GlaxoSmithKline, Glenmark, Gossamerbio, Menarini, Mundipharma, Novartis, Peptinnovate, Pfizer, Pulmatrix, Therevance and Verona.